Pharmacokinetics of Drugs That Inactivate Metabolic Enzymes
- 1 February 1991
- journal article
- research article
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 80 (2) , 121-127
- https://doi.org/10.1002/jps.2600800207
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Evidence for Lidocaine-Induced Enzyme InactivationJournal of Pharmaceutical Sciences, 1989
- The Effect of Galactosamine on Rat Liver Cytochrome P-450 ActivitiesThe Japanese Journal of Pharmacology, 1985
- Relationship Between Molecular Structure and Cytochrome P450−Metabolic Intermediate Complex FormationJournal of Pharmaceutical Sciences, 1984
- Effect of multiple administration of orphenadrine or mono-N-desmethylorphenadrine on cytochrome P-450 catalyzed reactions in the ratArchives of Toxicology, 1983
- Dual effects of macrolide antibiotics on rat liver cytochrome P-450Biochemical Pharmacology, 1983
- Formation of inactive cytochrome P-450 Fe(II)-metabolite complexes with several erythromycin derivatives but not with josamycin and midecamycin in ratsBiochemical Pharmacology, 1983
- Spectral interaction of orphenadrine and its metabolites with oxidized and reduced hepatic microsomal cytochrome P-450 in the ratBiochemical Pharmacology, 1982
- The Effects of Erythromycin on Theophylline Elimination in Normal MalesThe Journal of Clinical Pharmacology, 1982
- Enzyme deactivation in fixed bed reactors with michaelis-menten kineticsBiotechnology & Bioengineering, 1981
- Destruction of Cytochrome P 450 by Secobarbital and Other Barbiturates Containing Allyl GroupsScience, 1972